ChromaDex Announces Participation at The 20th Annual Global Investment Conference in New York City September 5, 2018
IRVINE, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age with its flagship ingredient NIAGEN® and consumer product TRU NIAGEN®, today …